HUP0003418A2 - Szintetikus, kétértékű, sLex-tartalmú polilaktózaminok és eljárás előállításukra - Google Patents

Szintetikus, kétértékű, sLex-tartalmú polilaktózaminok és eljárás előállításukra

Info

Publication number
HUP0003418A2
HUP0003418A2 HU0003418A HUP0003418A HUP0003418A2 HU P0003418 A2 HUP0003418 A2 HU P0003418A2 HU 0003418 A HU0003418 A HU 0003418A HU P0003418 A HUP0003418 A HU P0003418A HU P0003418 A2 HUP0003418 A2 HU P0003418A2
Authority
HU
Hungary
Prior art keywords
oligosaccharides
methods
synthetic
synthetic divalent
polylactosamines
Prior art date
Application number
HU0003418A
Other languages
English (en)
Inventor
Ossi Renkonen
Risto Renkonen
Original Assignee
Glycim Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycim Oy filed Critical Glycim Oy
Publication of HUP0003418A2 publication Critical patent/HUP0003418A2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02—Acyclic radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

A találmány szintetikus divalens oligoszacharidokra vonatkozik,amelyek egy (LN)n polilaktózamin vázat tartalmaznak, ahol n <> 5, ésahol a csoportok b1,3'-és/vagy b1,6'-kötésekkel vannak összekötve,amely a lánc végén a2,3-szalilezett és a1,3-fukozilezett kétmeghosszabbított elágazást tartalmazó hasonló kétágú elrendezésekkelvan összekötve. A találmány kiterjed az oligoszacharidokat tartalmazógyógyszerkészítményekre és az oligoszacharidok előállítására. Atalálmány szerinti oligoszacharidok felhasználhatók gyulladásosállapotok megelőzésére vagy kezelésére. Ó
HU0003418A 1997-09-05 1998-09-04 Szintetikus, kétértékű, sLex-tartalmú polilaktózaminok és eljárás előállításukra HUP0003418A2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5766097P 1997-09-05 1997-09-05

Publications (1)

Publication Number Publication Date
HUP0003418A2 true HUP0003418A2 (hu) 2001-02-28

Family

ID=22011973

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0003418A HUP0003418A2 (hu) 1997-09-05 1998-09-04 Szintetikus, kétértékű, sLex-tartalmú polilaktózaminok és eljárás előállításukra

Country Status (10)

Country Link
US (1) US6191271B1 (hu)
EP (1) EP1015464A2 (hu)
JP (1) JP2001515912A (hu)
AU (1) AU9073998A (hu)
CA (1) CA2302470A1 (hu)
HU (1) HUP0003418A2 (hu)
NO (1) NO20001091D0 (hu)
PL (1) PL339773A1 (hu)
SK (1) SK2812000A3 (hu)
WO (1) WO1999012944A2 (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7338932B2 (en) 2000-05-11 2008-03-04 Glycozym Aps Methods of modulating functions of polypeptide GalNAc-transferases and of screening test substances to find agents herefor, pharmaceutical compositions comprising such agents and the use of such agents for preparing medicaments
ATE361375T1 (de) * 2000-05-11 2007-05-15 Glycozym Aps Methoden zur modelierung die funktion von polypeptid galnac transferasen und zurscreening substanzen dafür
WO2002000879A2 (en) * 2000-06-28 2002-01-03 Glycofi, Inc. Methods for producing modified glycoproteins
WO2002089819A1 (en) * 2001-05-07 2002-11-14 Vereniging Voor Christelijk Wetenschappelijk Onderwijs Glycoconjugates and uses thereof
US20050203578A1 (en) * 2001-08-15 2005-09-15 Weiner Michael L. Process and apparatus for treating biological organisms
JP4934802B2 (ja) * 2005-05-30 2012-05-23 国立大学法人信州大学 リンパ系の細胞接着物質、リンパ系薬物輸送材およびそれを含有する薬剤
PL3116887T3 (pl) 2014-03-13 2021-09-06 Universität Basel Ligandy węglowodanowe, które wiążą się z przeciwciałami igm przeciwko glikoproteinie związanej z mieliną
JP6849667B2 (ja) 2015-09-16 2021-03-24 ウニヴェルズィテート バーゼル スフィンゴ糖脂質の糖鎖エピトープに対する抗体に結合する炭水化物リガンド

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079353A (en) 1987-12-02 1992-01-07 Chembiomed, Ltd. Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation
AU8007791A (en) 1990-06-15 1992-01-07 Cytel Corporation Intercellular adhesion mediators
US5211937A (en) 1990-07-30 1993-05-18 Glycomed Incorporated Method of determining a site of inflammation utilizing elam-1 ligands
EP0589951A1 (en) 1991-06-10 1994-04-06 Glycomed Incorporated Modified sialyl lewis?x compounds
US5352670A (en) 1991-06-10 1994-10-04 Alberta Research Council Methods for the enzymatic synthesis of alpha-sialylated oligosaccharide glycosides
WO1993015098A1 (en) 1992-01-31 1993-08-05 Nippon Shinyaku Co., Ltd. Lewis-type sugar chain derivative
JPH0686684A (ja) 1992-05-26 1994-03-29 Monsanto Co シアロ抱合体の合成
US5426178A (en) 1993-03-31 1995-06-20 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Synthesis of anti-inflammatory compounds, and novel trisaccharides useful in the synthesis of anti-inflammatory compounds
US5374541A (en) 1993-05-04 1994-12-20 The Scripps Research Institute Combined use of β-galactosidase and sialyltransferase coupled with in situ regeneration of CMP-sialic acid for one pot synthesis of oligosaccharides
US5409817A (en) 1993-05-04 1995-04-25 Cytel, Inc. Use of trans-sialidase and sialyltransferase for synthesis of sialylα2→3βgalactosides
HUT74506A (en) 1993-05-14 1997-01-28 Cytel Corp Sialyl lewis-x analogues as inhibitors of cellular adhesion
AU7083594A (en) 1993-07-02 1995-01-24 Nippon Shinyaku Co. Ltd. Galactosylmoranoline derivative
US5559103A (en) 1993-07-21 1996-09-24 Cytel Corporation Bivalent sialyl X saccharides
WO1995006057A1 (fr) 1993-08-23 1995-03-02 Nippon Shinyaku Co., Ltd. Derive de galactosylmoraniline
HUT77345A (hu) 1994-04-29 1998-03-30 Texas Biotechnology Corporation E-szelektin, P-szelektin vagy L-szelektin szialil-Lewis x-hez vagy szialil-Lewis a-hoz kapcsolódását gátló mannopiranoziloxi-bifenil származékok és ezeket tartalmazó gyógyszerkészítmények
CZ89098A3 (cs) * 1995-09-29 1998-09-16 Glycim Oy Syntetické polylaktosaminy obsahující až multivalentní sLEX a metody pro jejich použití

Also Published As

Publication number Publication date
PL339773A1 (en) 2001-01-02
WO1999012944A3 (en) 1999-08-26
SK2812000A3 (en) 2001-03-12
US6191271B1 (en) 2001-02-20
AU9073998A (en) 1999-03-29
WO1999012944A2 (en) 1999-03-18
NO20001091L (no) 2000-03-02
JP2001515912A (ja) 2001-09-25
EP1015464A2 (en) 2000-07-05
CA2302470A1 (en) 1999-03-18
NO20001091D0 (no) 2000-03-02

Similar Documents

Publication Publication Date Title
NO302366B1 (no) 4-merkaptoacetylamino-£2|benzazepinon(3)-derivater, og farmasöytisk preparat
WO2003031589A8 (en) Peptides and related compounds having thrombopoietic activity
DK1053239T3 (da) Gluccocorticoid-selektive, anti-inflammatoriske midler
HUP9702458A2 (hu) Humán interleukin-1-receptor járulékos fehérje
HUP9904261A2 (hu) Fém-aminosav komplexet tartalmazó hajkezelő kompozíció
ATE196913T1 (de) Neuartige peptidderivate
FI963169A (fi) Enkefalinaasin ja ACE:n inhibittoreina käyttökelpoisia uusia merkaptoasetyyliamido-1,3,4,5-tetrahydrobents/c/-atsepin-3-onidisulfidijohdannaisia
CA2320388A1 (en) Novel dihydroxyhexanoic acid derivatives
HUP0003418A2 (hu) Szintetikus, kétértékű, sLex-tartalmú polilaktózaminok és eljárás előállításukra
CA2215834A1 (en) Dna encoding human papillomavirus type 18
IT8947756A0 (it) Forme di somministrazione solide, che si decompongono rapidamente, relativo procedimento di produzione e loro impiego
PT775118E (pt) Derivados de benzimidazole com actividade dopaminergica
FR2722779B1 (fr) Composition de garant proteique et son application, notamment a la fertilisation des cereales
ITRM910430A1 (it) Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego
BR9611472A (pt) Compostos de di-terc-butilfenol contendo enxofre úteis como agentes antiinflamatórios
ATE177431T1 (de) Dinukleosid-5&#39;,5&#39;- pyrophosphate
DE3667914D1 (de) Entzuendungshemmende zusammensetzungen und verfahren.
IT8921513A0 (it) Derivati dell&#39;acido piroglutammico, loro preparazioni e composizioni farmacuetiche che li contengono.
CA2183320A1 (en) Novel Mercaptoacetylamide Disulfide Derivatives Useful as Inhibitors of Enkephalinase and Ace
DE69614552T2 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
HUP0003528A2 (hu) Dihidropoliprenolokat tartalmazó gyógyászati készítmények
ES2162123T3 (es) Dihidrato del (2r,3s)-3-terc.-butoxicarbonilamino-2-hidroxi-3-fenilpropionato de 4-10beta-diacetoxi-2alfa-benzoiloxi-5beta,20-epoxi-1-hidroxi-9-oxo-19-nor-ciclopropa(g)tax-11-eno-13alfa-ilo y su procedimiento de preparacion.
FR2634834B1 (fr) Systeme d&#39;assemblage par croisillon en forme de manchon permettant la libre rotation du manchon et des axes modulables, notamment pour plate-formes articulees
IT8653474V0 (it) Articolo indossabile per la valutazione dell ab bronzatura
RO93662A2 (ro) Echipament pentru administrarea ingrasamintelor naturale